Astellas to Acquire Ganymed Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) | Delayed: 16.02 -0.1 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.12 | 52 Week High | $19.40 | |||
| Open | $16.33 | 52 Week Low | $12.50 | |||
| Day High | $16.51 | P/E | N/A | |||
| Day Low | $15.27 | EPS | $0.00 | |||
| Volume | 99,348 | |||||
